4//SEC Filing
Sagent Pharmaceuticals, Inc. 4
Accession 0001562180-16-001773
CIK 0001369786operating
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:55 PM ET
Size
10.0 KB
Accession
0001562180-16-001773
Insider Transaction Report
Form 4
Drake Lorin
VP, Sales and Marketing
Transactions
- Award
Common Stock
2016-02-22+8,214→ 39,507 total - Tax Payment
Common Stock
2016-02-21$14.61/sh−449$6,560→ 31,628 total - Tax Payment
Common Stock
2016-02-22$13.00/sh−335$4,355→ 31,293 total - Award
Stock Option to Buy
2016-02-22+17,391→ 17,391 totalExercise: $14.61Exp: 2026-02-22→ Common Stock (17,391 underlying)
Footnotes (1)
- [F1]The option vests in four equal annual installments beginning on February 22, 2017.
Documents
Issuer
Sagent Pharmaceuticals, Inc.
CIK 0001369786
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001369786
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 5:55 PM ET
- Size
- 10.0 KB